Evidence map›Paper›PMID 33998895›Full record

ArticleCannabis and cannabinoid research2022

A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.

David J Nutt, Lawrence D Phillips, Michael P Barnes, Brigitta Brander, Helen Valerie Curran, Alan Fayaz, David P Finn, Tina Horsted, Julie Moltke, Chloe Sakal and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Cys-loop receptors on cannabinoids: All high?Frontiers in physiology · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Promising Health Benefits of AdjuvantEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Article
  15. Article
  16. [Cannabis- Summing it all up!]Der Anaesthesist · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

David J NuttDepartment of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Lawrence D PhillipsDepartment of Management, Emeritus Professor of Decision Science, London School of Economics and Political Science, London, United Kingdom.
Michael P BarnesMedical Cannabis Clinicians' Society, London, United Kingdom.
Brigitta BranderUniversity College London, London, United Kingdom.
Helen Valerie CurranUniversity College London, London, United Kingdom.
Alan FayazUniversity College London, London, United Kingdom.
David P FinnNational University of Ireland, Galway, Ireland.
Tina HorstedClinic Horsted, Copenhagen, Denmark.
Julie MoltkeClinic Horsted, Copenhagen, Denmark.
Chloe SakalDrug Science, London, United Kingdom.
Haggai SharonSagol Brain Institute, Tel-Aviv, Israel.
Saoirse E O'SullivanCanPharmaConsulting, Nottingham, United Kingdom.
Tim WilliamsAWP Mental Health NHS Trust, Bristol, United Kingdom.
Gregor ZornEuropean Cannabinoid Therapy Association, Worcester, United Kingdom.
Anne K SchlagDrug Science, London, United Kingdom.
University College London · GBAllen Institute for Brain Science · USBioPharm (United Kingdom) · GBImperial College London · GBLondon School of Economics and Political Science · GBNorth Bristol NHS Trust · GBOllscoil na Gaillimhe – University of Galway · IERoyal Society of Medicine · GBUniversity of Worcester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolCannabinoidsCannabisHallucinogensNeuralgiaAdultAnalgesicsCannabinoid Receptor AgonistsDecision Support TechniquesDronabinolHumansQuality of LifeAnalgesicsCannabidiolCannabinoid Receptor AgonistsCannabinoidsDronabinolHallucinogensanalgesicscannabis-based medical productsCBMPMCDAmulticriteria decision analysisneuropathic pain

Identifiers

PMID33998895
PMCPMC9418467
OpenAlexW3136095988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.